Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ohnuma

Showing results (41-50 of 172) with videos related to

Pageof 18
Sort By:
European Journal of Cancer|May 1, 1981
Inhibition by chemotherapeutic agents of human bone marrow progenitor cells and clonogenic cells of a lymphoblastic cell lineC K Williams, T Ohnuma, J F Holland
Cancer Treatment Reports|January 1, 1980
Initial clinical study with vindesine: tolerance to weekly iv bolus and 24-hour infusionT Ohnuma, E M Greenspan, J F Holland
FEBS Letters|June 15, 1992
Increase in protein kinase C activity is associated with human fibroblast growth inhibitionV Rogalsky, G Todorov, T Den, et al.
Cancer Treatment Reports|April 1, 1980
Initial clinical study with N-(phosphonacetyl)-L-aspartic acid (PALA) in patients with advanced cancerR D Hart, T Ohnuma, J F Holland
Cancer|February 1, 1979
Management of asparaginase induced hemorrhagic pancreatitis complicated by pseudocystR Greenstein, C Nogeire, T Ohnuma, et al.
Japanese Journal of Cancer Research : Gann|November 1, 1992
Flow cytometric analyses of the characteristics of tumor cells treated with two platinum compounds: 1,1-cyclobutanedicarboxylato(2-aminomethylpyrrolidine)- platinum(II) and cisplatinS Inoue, S Mizuno, M Ito, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
A human leukemia cell line made resistant to two folate analogues, trimetrexate and N10-propargyl-5,8-dideazafolic acid (CB3717)Y Takemura, T Ohnuma, H Miyachi, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|July 1, 1991
[A case of congenital malformation of the biliary duct with strange dilatation and interlobar connection of the intrahepatic biliary duct]T Ohnuma, N Takeyama, H Yamase, et al.
Cancer Chemotherapy and Pharmacology|June 10, 1998
Reversal of multidrug resistance by a liposome-MDR1 ribozyme complexY Masuda, H Kobayashi, J F Holland, et al.
Cancer|October 1, 1978
Phase I study with neocarzinostatin: tolerance to two hour infusion and continuous infusionT Ohnuma, C Nogeire, J Cuttner, et al.
Pageof 18

Showing results (41-50 of 172) with videos related to

Sort By:
Pageof 18
European Journal of Cancer|May 1, 1981
Inhibition by chemotherapeutic agents of human bone marrow progenitor cells and clonogenic cells of a lymphoblastic cell lineC K Williams, T Ohnuma, J F Holland
Cancer Treatment Reports|January 1, 1980
Initial clinical study with vindesine: tolerance to weekly iv bolus and 24-hour infusionT Ohnuma, E M Greenspan, J F Holland
FEBS Letters|June 15, 1992
Increase in protein kinase C activity is associated with human fibroblast growth inhibitionV Rogalsky, G Todorov, T Den, et al.
Cancer Treatment Reports|April 1, 1980
Initial clinical study with N-(phosphonacetyl)-L-aspartic acid (PALA) in patients with advanced cancerR D Hart, T Ohnuma, J F Holland
Cancer|February 1, 1979
Management of asparaginase induced hemorrhagic pancreatitis complicated by pseudocystR Greenstein, C Nogeire, T Ohnuma, et al.
Japanese Journal of Cancer Research : Gann|November 1, 1992
Flow cytometric analyses of the characteristics of tumor cells treated with two platinum compounds: 1,1-cyclobutanedicarboxylato(2-aminomethylpyrrolidine)- platinum(II) and cisplatinS Inoue, S Mizuno, M Ito, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
A human leukemia cell line made resistant to two folate analogues, trimetrexate and N10-propargyl-5,8-dideazafolic acid (CB3717)Y Takemura, T Ohnuma, H Miyachi, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|July 1, 1991
[A case of congenital malformation of the biliary duct with strange dilatation and interlobar connection of the intrahepatic biliary duct]T Ohnuma, N Takeyama, H Yamase, et al.
Cancer Chemotherapy and Pharmacology|June 10, 1998
Reversal of multidrug resistance by a liposome-MDR1 ribozyme complexY Masuda, H Kobayashi, J F Holland, et al.
Cancer|October 1, 1978
Phase I study with neocarzinostatin: tolerance to two hour infusion and continuous infusionT Ohnuma, C Nogeire, J Cuttner, et al.
Pageof 18